[F&N] QoQ Annualized Quarter Result on 30-Jun-2013 [#3]

Stock
[F&N] FRASER & NEAVE HOLDINGS BHD
Announcement Date
06-Aug-2013
Admission Sponsor
-
Sponsor
-
Financial Year
30-Sep-2013
Quarter
30-Jun-2013 [#3]
Profit Trend
QoQ- 7.65%
YoY- -10.46%
Quarter Report
Latest QR
Upcoming QR
F&N's Result
F&N's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Revenue 3,766,312 3,791,044 3,508,225 3,480,929 3,438,970 3,416,844 3,171,923 12.14%
PBT 337,792 344,520 307,765 294,113 262,886 264,432 230,208 29.15%
Tax -64,096 -69,492 -48,307 -54,844 -40,622 -37,144 43,782 -
NP 273,696 275,028 259,458 239,269 222,264 227,288 273,990 -0.07%
-
NP to SH 273,714 275,064 259,485 239,293 222,282 227,288 274,030 -0.07%
-
Tax Rate 18.97% 20.17% 15.70% 18.65% 15.45% 14.05% -19.02% -
Total Cost 3,492,616 3,516,016 3,248,767 3,241,660 3,216,706 3,189,556 2,897,933 13.26%
-
Net Worth 1,638,634 1,702,777 1,643,168 1,545,312 1,559,797 1,622,474 1,545,254 3.99%
Dividend
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Div 160,578 - 218,119 - 145,097 - 209,403 -16.23%
Div Payout % 58.67% - 84.06% - 65.28% - 76.42% -
Equity
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Net Worth 1,638,634 1,702,777 1,643,168 1,545,312 1,559,797 1,622,474 1,545,254 3.99%
NOSH 364,952 363,841 363,532 363,602 362,743 363,783 361,040 0.72%
Ratio Analysis
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
NP Margin 7.27% 7.25% 7.40% 6.87% 6.46% 6.65% 8.64% -
ROE 16.70% 16.15% 15.79% 15.49% 14.25% 14.01% 17.73% -
Per Share
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
RPS 1,032.00 1,041.95 965.04 957.34 948.04 939.25 878.55 11.34%
EPS 75.00 75.60 71.40 65.87 61.20 62.40 75.90 -0.79%
DPS 44.00 0.00 60.00 0.00 40.00 0.00 58.00 -16.83%
NAPS 4.49 4.68 4.52 4.25 4.30 4.46 4.28 3.24%
Adjusted Per Share Value based on latest NOSH - 363,079
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
RPS 1,026.86 1,033.61 956.50 949.05 937.61 931.58 864.81 12.14%
EPS 74.63 74.99 70.75 65.24 60.60 61.97 74.71 -0.07%
DPS 43.78 0.00 59.47 0.00 39.56 0.00 57.09 -16.23%
NAPS 4.4676 4.6425 4.48 4.2132 4.2527 4.4236 4.213 3.99%
Price Multiplier on Financial Quarter End Date
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Date 31/03/14 31/12/13 30/09/13 28/06/13 29/03/13 31/12/12 28/09/12 -
Price 18.02 18.50 18.60 18.32 18.50 18.02 18.20 -
P/RPS 1.75 1.78 1.93 1.91 1.95 1.92 2.07 -10.60%
P/EPS 24.03 24.47 26.06 27.84 30.19 28.84 23.98 0.13%
EY 4.16 4.09 3.84 3.59 3.31 3.47 4.17 -0.16%
DY 2.44 0.00 3.23 0.00 2.16 0.00 3.19 -16.37%
P/NAPS 4.01 3.95 4.12 4.31 4.30 4.04 4.25 -3.80%
Price Multiplier on Announcement Date
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Date 07/05/14 10/02/14 07/11/13 06/08/13 07/05/13 05/02/13 08/11/12 -
Price 18.08 18.30 18.58 18.46 18.08 17.92 18.74 -
P/RPS 1.75 1.76 1.93 1.93 1.91 1.91 2.13 -12.28%
P/EPS 24.11 24.21 26.03 28.05 29.50 28.68 24.69 -1.57%
EY 4.15 4.13 3.84 3.57 3.39 3.49 4.05 1.64%
DY 2.43 0.00 3.23 0.00 2.21 0.00 3.09 -14.81%
P/NAPS 4.03 3.91 4.11 4.34 4.20 4.02 4.38 -5.40%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment